An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Multiple molecular profiling methods are required to study urothelial non-muscle-invasive bladder cancer (NMIBC) due to its heterogeneity. Here the authors integrate multi-omics data of 834 NMIBC patients, identifying a molecular subgroup associated with multiple alterations and worse outcomes.
Enregistré dans:
Documents similaires
-
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
par: Ann Taber, et autres
Publié: (2020) -
Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
par: Ann Taber, et autres
Publié: (2021) -
Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
par: Pontus Eriksson, et autres
Publié: (2013) -
Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.
par: Moniek M Vedder, et autres
Publié: (2014) -
Impact of Sediment Layer on Longitudinal Dispersion in Sewer Systems
par: Marek Sokáč, et autres
Publié: (2021)